Dr Reddy's Laboratories Long Term Debt 2010-2025 | RDY

Dr Reddy's Laboratories long term debt for the quarter ending March 31, 2025 was $92M, a 27.78% increase year-over-year.

  • Dr Reddy's Laboratories long term debt for 2025 was $0.092B, a 27.78% increase from 2024.
  • Dr Reddy's Laboratories long term debt for 2024 was $0.072B, a 350% increase from 2023.
  • Dr Reddy's Laboratories long term debt for 2023 was $0.016B, a 78.95% decline from 2022.

Dr Reddy's Laboratories Long Term Debt 2010-2025 | RDY

  • Dr Reddy's Laboratories long term debt for 2025 was $0.092B, a 27.78% increase from 2024.
  • Dr Reddy's Laboratories long term debt for 2024 was $0.072B, a 350% increase from 2023.
  • Dr Reddy's Laboratories long term debt for 2023 was $0.016B, a 78.95% decline from 2022.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$18.4B
BridgeBio Pharma (BBIO)$8.8B
Bausch Health Cos (BHC)$2.3B
Supernus Pharmaceuticals (SUPN)$1.8B
Amphastar Pharmaceuticals (AMPH)$972M
Taysha Gene Therapies (TSHA)$552M
Personalis (PSNL)$547M
Assembly Biosciences (ASMB)$143M
Sol-Gel Technologies (SLGL)$23M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M